Annovis Bio Stock (NYSE:ANVS), Quotes and News Summary

Q: What sector and industry does Annovis Bio (ANVS) operate in?

Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Annovis Bio Stock (NYSE: ANVS) stock price, news, charts, stock research, profile.

Open	$8.000
Close	-
Volume / Avg.	276.233K / 528.874K
Day Range	7.380 - 8.120
52 Wk Range	4.790 - 22.490
Market Cap	$88.702M
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	48
Short Interest	19.24%
Days to Cover	1.17

Recent News

S&P 500 Edges Higher; ON Semiconductor Earnings Top Views

Avi Kapoor

Why Is Alzheimer's-Focused Annovis Bio Stock Nosediving On Monday?

Annovis Bio faces setbacks in Phase 2/3 Alzheimer's study, revealing minimal change in patients' conditions. Despite slight improvements in mild cases, results show no significant difference in treatment groups.

Vandana Singh

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Annovis Bio (ANVS) stock?

You can purchase shares of Annovis Bio (NYSE: ANVS) through any online brokerage.

View our list of the best stock brokerages.

Who are Annovis Bio's (ANVS) competitors?

Other companies in Annovis Bio’s space includes: Anixa Biosciences (NASDAQ:ANIX), Connect Biopharma Hldgs (NASDAQ:CNTB), Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP) and Barinthus Biotherapeutics (NASDAQ:BRNS).

What is the target price for Annovis Bio (ANVS) stock?

The latest price target for Annovis Bio (NYSE: ANVS) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 23.00 expecting ANVS to rise to within 12 months (a possible 189.67% upside). 13 analyst firms have reported ratings in the last year.

Current Stock Price for Annovis Bio (ANVS)?

The stock price for Annovis Bio (NYSE: ANVS) is $7.94 last updated Today at May 17, 2024 at 1:29 PM EDT.

Does Annovis Bio (ANVS) pay a dividend?

There are no upcoming dividends for Annovis Bio.

When is Annovis Bio (NYSE:ANVS) reporting earnings?

Annovis Bio’s Q2 earnings are confirmed for Tuesday, August 13, 2024.

Is Annovis Bio (ANVS) going to split?

There is no upcoming split for Annovis Bio.

What sector and industry does Annovis Bio (ANVS) operate in?

Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-